Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells

Immunology

Volumn 124, Issue 2, 2008, Pages 265-276

  Maruvada, Ravi ^a   Blom, Anna M ^b   Prasadarao, Nemani V ^a,c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bacteria; Complement; Endothelial cells; Invasion; Meningitis

Indexed keywords

BINDING PROTEIN; COMPLEMENT FACTOR H; PROTEIN C4;

ARTICLE; BACTERIAL SURVIVAL; CELL DIFFERENTIATION; CELL SURVIVAL; CORD SERUM; ENDOTHELIUM CELL; ESCHERICHIA COLI; FLOW CYTOMETRY; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

ADULT; AGING; BLOOD BACTERICIDAL ACTIVITY; BRAIN; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; FETAL BLOOD; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INFANT, NEWBORN; PHAGOCYTOSIS; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 43749101614     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02764.x     Document Type: Article

References (41)

1. Kirschfink M, Mollnes TE. Modern complement analysis. Clin Diagn Lab Immunol 2003 10 : 982 9.
2. Gadjeva M, Thiel S, Jensenius JC. The mannan-binding-lectin pathway of the innate immune response. Curr Opin Immunol 2000 13 : 74 8.
3. Gewurz H, Pickering RJ, Muschel LH, Mergenhagen SE, Good RA. Complement-dependent biological functions in complement deficiency in man. Lancet 1966 13 : 356 60.
4. Bladen HA, Gewurz H, Mergenhagen SE. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med 1967 125 : 767 86.
5. Marcus RL, Shin HS, Mayer MM. An alternate complement pathway: C-3 cleaving activity, not due to C42a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. Proc Natl Acad Sci USA 1971 68 : 1351 4.
6. Dave S, Brooks-Walter A, Pangburn MK, McDaniel LS. PspC, a pneumococcal surface protein, binds human factor H. Infect Immun 2001 69 : 3435 7.
7. Lindahl G, Sjobring U, Johnsson E. Human complement regulators: a major target for pathogenic microorganisms. Curr Opin Immunol 2000 12 : 44 51.
8. Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 1988 85 : 1657 61.
9. Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC. A novel interaction of outer membrane protein A with C4b binding protein mediates serum-resistance of Escherichia coli K1. J Immunol 2002 169 : 6352 60.
10. Wooster DG, Maruvada R, Blom AM, Prasadarao NV. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology 2006 117 : 482 93.
11. Sukumaran SK, Shimada H, Prasadarao NV. Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect Immun 2003 71 : 5951 61.
12. Aoyagi Y, Adderson EE, Min JG, Matsushita M, Fujita T, Takahashi S, Okuwaki Y, Bohnsack JF. Role of l-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J Immunol 2005 174 : 418 25.
13. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981 68 : 544 9.
14. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med 1980 151 : 1275 87.
15. Takahashi S, Aoyagi Y, Adderson EE, Okuwaki Y, Bohnsack JF. Capsular sialic acid limits C5a production on type III group B streptococci. Infect Immun 1999 67 : 1866 70.
16. Marques MB, Kasper DL, Pangburn MK, Wessels MR. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun 1992 60 : 3986 93.
17. Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, Kim KS. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun 1996 64 : 146 53.
18. Bremer E., Silhavy TJ, Maldener M, Cole ST. Isolation and characterization of mutants deleted for the sulA-ompA region of the E. coli K-12 chromosome. FEMS Microbiol Lett 1986 33 : 173 8.
19. Weiser JN, Gotschlich EC. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K1. Infect Immun 1991 59 : 2252 8.
20. Rubens CE, Raff HV, Jackson JC, Chi EY, Bielitzki JT, Hillier SL. Pathophysiology and histopathology of group B Streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis 1991 164 : 320 30.
21. Rubens CE, Heggen LM, Haft RF, Wessels MR. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol 1993 8 : 843 55.
22. Abdullah M, Davies RJ, Hill JA. The application of DNA-cellulose chromatography in the isolation of immunoglobulin M and complement component C4b-binding protein from human serum. J Chromatogr 1985 25 : 129 36.
23. Holme ER, Qi M, Ahmed AE, Veitch J, Auda G, Whaley K. Purification and characterization of RHP (factor H) and study of its interactions with the first component of complement. Mol Immunol 1992 29 : 957 64.
24. Lappegard KT, Fung M, Bergseth G, Riesenfeld J, Lambris JD, Videm V, Mollnes TE. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg 2004 77 : 932 41.
25. Mollnes TE, Brekke OL, Fung M et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002 100 : 1869 77.
26. Shyur SD, Raff HV, Bohnsack JF, Kelsey DK, Hill HR. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci. J Immunol 1992 148 : 1879 84.
27. Levy NJ, Kasper DL. Antibody-independent and -dependent opsonization of group B streptococcus requires the first component of complement C1. Infect Immun 1985 49 : 19 24.
28. Payne NR, Concepcion NF, Anthony BF. Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci. Infect Immun 1990 58 : 3663 70.
29. Rainard P. Assessment by a fluorochrome microassay of phagocytic killing of group B streptococci adherent to glass. J Immunol Methods 1986 94 : 113 8.
30. Lassiter HA, Watson SW, Seifring ML, Tanner JE. Complement factor 9 deficiency in serum of human neonates. J Infect Dis 1992 166 : 53 7.
31. Lassiter HA, Walz BM, Wilson JL et al. The administration of complement component C9 enhances the survival of neonatal rats with Escherichia coli sepsis. Pediatr Res 1997 42 : 128 36.
32. Winkelstein JA, Kurlandsky LE, Swift AJ. Defective activation of the third component of complement in the sera of newborn infants. Pediatr Res 1979 13 : 1093 6.
33. Pandiripally V, Wei L, Skerka C, Zipfel PF, Cue D. Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect Immun 2003 71 : 7119 28.
34. Meri T, Blom AM, Hartmann A, Lenk D, Meri S, Zipfel PF. The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect Immun 2004 72 : 6633 41.
35. Lassiter HA, Wilson JL, Feldhoff RC, Hoffpauir JM, Klueber KM. Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli. Pediatr Res 1994 35 : 389 96.
36. Nupponen I, Venge P, Pohjavuori M, Lassus P, Andersson S. Phagocyte activation in preterm infants following premature rupture of the membranes or chorioamnionitis. Acta Paediatr 2000 89 : 1207 12.
37. Rooijakkers SH, Ruyken M, Roos A et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 2005 6 : 920 7.
38. Smith CL, Baker CJ, Anderson DC, Edwards MS. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J Infect Dis 1990 162 : 489 95.
39. Prasadarao NV. Identification of Escherichia coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun 2002 70 : 4556 63.
40. Kotarsky H, Hellwage J, Johnsson E, Skerka C, Svensson HG, Lindahl G, Sjobring U, Zipfel PF. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol 1998 160 : 3349 54.
41. Blackmore TK, Fischetti VA, Sadlon TA, Ward HM, Gordon DL. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun 1998 66 : 1427 31.